BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21937986)

  • 1. The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity.
    Bakema JE; van Egmond M
    Mucosal Immunol; 2011 Nov; 4(6):612-24. PubMed ID: 21937986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.
    Ben Mkaddem S; Rossato E; Heming N; Monteiro RC
    Autoimmun Rev; 2013 Apr; 12(6):666-9. PubMed ID: 23201915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.
    Aleyd E; Heineke MH; van Egmond M
    Immunol Rev; 2015 Nov; 268(1):123-38. PubMed ID: 26497517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fc receptor for IgA (FcalphaRI, CD89).
    Otten MA; van Egmond M
    Immunol Lett; 2004 Mar; 92(1-2):23-31. PubMed ID: 15081523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA and FcαRI: Pathological Roles and Therapeutic Opportunities.
    Breedveld A; van Egmond M
    Front Immunol; 2019; 10():553. PubMed ID: 30984170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IgA and IgA fc receptors in inflammation.
    Monteiro RC
    J Clin Immunol; 2010 Jan; 30(1):1-9. PubMed ID: 19834792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity.
    van Egmond M; van Garderen E; van Spriel AB; Damen CA; van Amersfoort ES; van Zandbergen G; van Hattum J; Kuiper J; van de Winkel JG
    Nat Med; 2000 Jun; 6(6):680-5. PubMed ID: 10835685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
    Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
    MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
    Herr AB; Ballister ER; Bjorkman PJ
    Nature; 2003 Jun; 423(6940):614-20. PubMed ID: 12768205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum IgA Immune Complexes Promote Proinflammatory Cytokine Production by Human Macrophages, Monocytes, and Kupffer Cells through FcαRI-TLR Cross-Talk.
    Hansen IS; Hoepel W; Zaat SAJ; Baeten DLP; den Dunnen J
    J Immunol; 2017 Dec; 199(12):4124-4131. PubMed ID: 29118246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rediscovering IgA.
    Mantis NJ
    Mucosal Immunol; 2011 Nov; 4(6):588-9. PubMed ID: 22005880
    [No Abstract]   [Full Text] [Related]  

  • 12. FcalphaRI (CD89) alleles determine the proinflammatory potential of serum IgA.
    Wu J; Ji C; Xie F; Langefeld CD; Qian K; Gibson AW; Edberg JC; Kimberly RP
    J Immunol; 2007 Mar; 178(6):3973-82. PubMed ID: 17339498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
    Valerius T; Stockmeyer B; van Spriel AB; Graziano RF; van den Herik-Oudijk IE; Repp R; Deo YM; Lund J; Kalden JR; Gramatzki M; van de Winkel JG
    Blood; 1997 Dec; 90(11):4485-92. PubMed ID: 9373259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA and the IgA Fc receptor.
    van Egmond M; Damen CA; van Spriel AB; Vidarsson G; van Garderen E; van de Winkel JG
    Trends Immunol; 2001 Apr; 22(4):205-11. PubMed ID: 11274926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal capsular polysaccharide-specific IgA triggers efficient neutrophil effector functions via FcalphaRI (CD89).
    van der Pol W; Vidarsson G; Vilé HA; van de Winkel JG; Rodriguez ME
    J Infect Dis; 2000 Oct; 182(4):1139-45. PubMed ID: 10979910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin A-mediated protection against Bordetella pertussis infection.
    Hellwig SM; van Spriel AB; Schellekens JF; Mooi FR; van de Winkel JG
    Infect Immun; 2001 Aug; 69(8):4846-50. PubMed ID: 11447159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA Fc receptors.
    Monteiro RC; Van De Winkel JG
    Annu Rev Immunol; 2003; 21():177-204. PubMed ID: 12524384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide mimetics of immunoglobulin A (IgA) and FcαRI block IgA-induced human neutrophil activation and migration.
    Heineke MH; van der Steen LPE; Korthouwer RM; Hage JJ; Langedijk JPM; Benschop JJ; Bakema JE; Slootstra JW; van Egmond M
    Eur J Immunol; 2017 Oct; 47(10):1835-1845. PubMed ID: 28736835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Episodes of natural selection shaped the interactions of IgA-Fc with FcalphaRI and bacterial decoy proteins.
    Abi-Rached L; Dorighi K; Norman PJ; Yawata M; Parham P
    J Immunol; 2007 Jun; 178(12):7943-54. PubMed ID: 17548632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of inflammatory responses by immunoglobulin A receptor (FcαRI) inhibits the development of Toll-like receptor-9 signalling-accelerated glomerulonephritis.
    Watanabe T; Kanamaru Y; Liu C; Suzuki Y; Tada N; Okumura K; Horikoshi S; Tomino Y
    Clin Exp Immunol; 2011 Nov; 166(2):235-50. PubMed ID: 21985370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.